Upload
hafizarqursoy
View
1
Download
0
Embed Size (px)
DESCRIPTION
55555
Citation preview
Abstract
DAPSONE HYPERSENSITIVITY SYNDROME IN LEPROSY
Zakiyah Salim, Maya Milani B, St.Musafirah, Dianawaty A, Ratna Komala D,
Muh.Dali Amiruddin, Faridha S Ilyas, Sri Vitayani M
Dermato-Venereology Department, Medical Faculty of Hasanuddin University/ Dr.Wahidin Sudirohusodo General Hospital, Makassar, Indonesia
ABSTRACT
Background: Dapsone Hypersensitivity Syndrome (DHS) is a rare well recognized serious adverse effect characterized by fever, skin rashes, generalized lymphadenopathy, hepatitis and hepato-splenomegaly. Hipersensitivity reaction occur during first 6 weeks, but can occur after 6 months.
Objective: to find out the total cases for 2 years of dapson hypersensitivity syndrome in the wahidin sudirohusodo general hospital, Makassar, Indonesia.
Method: A retrospective study was carried out taken from medical record and registration book. (January 2005- December 2006)
Result: Five patients with dapson hypersensitivity syndrome were reported. All patients received dapsone as a part of MDT for leprosy. Fever, jaundice, skin lesion were detected in 5 cases, but 1 case appearance like morbiliform. Lymphadenopathy (2 cases), splenomegaly and acut psychosis (1 case). Laboratory data on admission included : low hemoglobin, leucocytosis, elevated level of serum liver enzymes, erythrocyte sedimentation, raised bilirubin and hypoproteinemia. The interval between start of dapsone therapy and appearance of symptoms varied from 2-7 weeks. But one case the clinical manifestation occur 8 months after consumption of Multi drug treatment(MDT).
All cases were treated with corticosteroids after withdrawing dapsone, MDT was continued by replacing dapsone with minocyclin.
Conclusion: There are significant clinical improvement in all cases, such as complete resolution of skin lesions and other symptoms.
Key Words: Dapsone syndrome, leprosy, multi drug treatmentPAGE 1